Ploug Group

Current projects

Biochemical characterization of various ligand interactions with uPAR studied by site-directed mutagenesis, surface plasmon resonance and hydrogen-deuterium exchange.Development, characterization and refinements of synthetic peptide antagonists of uPAR.

Studies on the histopathological expression and prognostic impact of C4.4A in human cancer with particular emphasis on lung cancer.